Provided by Tiger Trade Technology Pte. Ltd.

AC Immune SA

2.90
+0.26009.85%
Post-market: 2.83-0.0699-2.41%19:30 EDT
Volume:442.01K
Turnover:1.26M
Market Cap:295.14M
PE:-5.51
High:2.95
Open:2.66
Low:2.65
Close:2.64
52wk High:4.00
52wk Low:2.03
Shares:101.77M
Float Shares:39.19M
Volume Ratio:2.61
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5264
EPS(LYR):-0.8828
ROE:-78.53%
ROA:-16.04%
PB:6.73
PE(LYR):-3.29

Loading ...

AC Immune Q1 EPS $(0.19) Beats $(0.20) Estimate, Sales $1.429M Beat $1.000M Estimate

Benzinga Earnings
·
Apr 30

AC Immune Q1 net loss narrows 22.2% to CHF 14.8 million

Reuters
·
Apr 30

AC Immune Q1 Net Income CHF -14.8 Million

THOMSON REUTERS
·
Apr 30

AC Immune First Quarter 2026 Financial and Corporate Updates

THOMSON REUTERS
·
Apr 30

AC Immune starts final ABATE trial cohort testing ACI-24 Alzheimer’s vaccine candidate

Reuters
·
Apr 30

AC Immune CEO Andrea Pfeifer buys 10,000 shares worth $31,425

Reuters
·
Apr 16

Analysts Are Bullish on Top Healthcare Stocks: Insmed (INSM), AC Immune SA (ACIU)

TIPRANKS
·
Apr 08

Leerink calls AC Immune- Eli Lilly Tau amendment ‘great news’

TIPRANKS
·
Apr 08

AC Immune Extends Alzheimer's Drug Pact With Eli Lilly

Dow Jones
·
Apr 07

AC Immune announces amendment to Eli Lilly license pact, to receive CHF 10M

TIPRANKS
·
Apr 07

AC Immune Sa - Under Amendment, Co to Receive CHF10 Mln Upfront Payment and Phase 1 Milestone Payment

THOMSON REUTERS
·
Apr 07

AC Immune Sa - Ind-Enabling Studies to Commence in H1 2026

THOMSON REUTERS
·
Apr 07

AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement With Lilly

THOMSON REUTERS
·
Apr 07

AC Immune Sa - Eligible for Over CHF1.7 Bln in Milestones Plus Tiered Royalties

THOMSON REUTERS
·
Apr 07

AC Immune Sa - Amended Agreement Covers Development of New Tau Morphomer Candidates

THOMSON REUTERS
·
Apr 07

Press Release: AC Immune Announces Amendment to Morphomer (R) Tau License and Collaboration Agreement with Lilly

Dow Jones
·
Apr 07

AC Immune files Form 3 as director Martin Zuegel reports beneficial ownership

Reuters
·
Apr 02

AC Immune SA COO Piergiorgio Donati files initial beneficial ownership statement

Reuters
·
Mar 20

BUZZ-U.S. STOCKS ON THE MOVE-Rivian,  Biohaven, CervoMed

Reuters
·
Mar 19

BUZZ-AC Immune rises as early data shows new brain scan can spot dementia protein

Reuters
·
Mar 19